Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification.

CONCLUSION: During the 3-year study, there were no significant differences in the CVR between the ETV and LdT groups if appropriate rescue therapy was considered.
PMID: 29611400 [PubMed - in process]

Source: Yonsei Medical Journal - April 4, 2018 Category: Universities & Medical Training Authors: Choi JW, Kim SH, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Lee YK, Lee CK Tags: Yonsei Med J Source Type: research